Oaktree Acquisition Corp. Iii Life Sciences · NASDAQ:OACC
Goldman Sachs Group Inc's stake in Oaktree Acquisition Corp. Iii Life Sciences fell to 4.10% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 12, 2025
Goldman Sachs Group Inc's stake in Oaktree Acquisition Corp. Iii Life Sciences fell to 4.10%, 803,487 shares, as a passive investor on Jun 30, 2025. Filed Aug 12, 2025 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 803,487
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 4.10% | 803,487 |
| GOLDMAN SACHS & CO. LLC | 4.10% | 803,487 |
Source
Related
- Oaktree Acquisition Corp. Iii Life Sciences
- Goldman Sachs Group Inc
- Oaktree Acquisition Corp. Iii Life Sciences shareholders
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 9, 2025
- Form 4 · Oaktree Acquisition Holdings III LS, LLC · Oct 23, 2026
- Schedule 13G · Decagon Asset Management LLP · Aug 14, 2026
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G · Fort Baker Capital Management LP · May 15, 2026
- Schedule 13G/A · Barclays PLC · Feb 11, 2026